Goldman Sachs Group Inc Morpho Sys Ag Transaction History

Goldman Sachs Group Inc

  • $555 Billion
  • Q1 2024

A detailed history of Goldman Sachs Group Inc transactions in Morpho Sys Ag stock. As of the latest transaction made, Goldman Sachs Group Inc holds 636,016 shares of MOR stock, worth $11.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
636,016
Previous 275,937 130.49%
Holding current value
$11.6 Million
Previous $2.73 Million 322.45%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$8.6 - $18.18 $3.1 Million - $6.55 Million
360,079 Added 130.49%
636,016 $11.5 Million
Q4 2023

Feb 13, 2024
BUY
$4.55 - $9.9 $1.07 Million - $2.34 Million
236,171 Added 593.9%
275,937 $2.73 Million
Q3 2023

May 14, 2024
SELL
$6.72 - $8.6 $1.59 Million - $2.03 Million
-236,171 Reduced 85.59%
39,766 $267,000
Q3 2023

Nov 14, 2023
BUY
$6.72 - $8.6 $65,627 - $83,987
9,766 Added 32.55%
39,766 $267,000
Q2 2023

May 14, 2024
SELL
$3.95 - $7.74 $1,576 - $3,088
-399 Reduced 1.31%
30,000 $224,000
Q2 2023

Aug 14, 2023
SELL
$3.95 - $7.74 $1,576 - $3,088
-399 Reduced 1.31%
30,000 $224,000
Q1 2023

May 14, 2024
BUY
$3.56 - $5.22 $1,420 - $2,082
399 Added 1.33%
30,399 $120,000
Q1 2023

May 11, 2023
BUY
$3.56 - $5.22 $1,420 - $2,082
399 Added 1.33%
30,399 $120,000
Q4 2022

May 14, 2024
SELL
$3.21 - $5.74 $41 - $74
-13 Reduced 0.04%
30,000 $107,000
Q4 2022

Feb 13, 2023
SELL
$3.21 - $5.74 $41 - $74
-13 Reduced 0.04%
30,000 $107,000
Q3 2022

May 14, 2024
BUY
$4.14 - $22.13 $53 - $287
13 Added 0.04%
30,013 $151,000
Q3 2022

Nov 10, 2022
BUY
$4.14 - $22.13 $53 - $287
13 Added 0.04%
30,013 $150,000
Q2 2022

May 14, 2024
SELL
$4.51 - $7.39 $1.11 Million - $1.82 Million
-245,937 Reduced 89.13%
30,000 $145,000
Q2 2022

Aug 15, 2022
SELL
$4.51 - $7.39 $28,913 - $47,377
-6,411 Reduced 17.61%
30,000 $145,000
Q1 2022

May 16, 2022
SELL
$5.87 - $9.73 $26,303 - $43,600
-4,481 Reduced 10.96%
36,411 $247,000
Q4 2021

Feb 14, 2022
BUY
$9.08 - $12.45 $86,959 - $119,233
9,577 Added 30.58%
40,892 $385,000
Q3 2021

Nov 10, 2021
BUY
$11.76 - $19.51 $368,264 - $610,955
31,315 New
31,315 $368,000

Others Institutions Holding MOR

# of Institutions
72
Shares Held
11.3M
Call Options Held
320K
Put Options Held
1.1M
View Full List

About MorphoSys AG

MOR Quotes by TradingView
  • Ticker MOR
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 136,614,000
  • Market Cap $2.49B
  • Description
  • MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...
More about MOR
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email